Bionano Genomics Inc. (BNGO)
NASDAQ · Healthcare
Bionano Genomics Inc. Total Liabilities 2017–2025
Bionano Genomics Inc. annual total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Bionano Genomics Inc. total liabilities as of December 31, 2025: 29.2M, a 29.39% decrease year-over-year.
- Bionano Genomics Inc. total liabilities for 2025 were 29.2M, a 29.39% decrease from 2024.
- Bionano Genomics Inc. total liabilities for 2024 were 41.3M, a 65.08% decrease from 2023.
- Bionano Genomics Inc. total liabilities for 2023 were 118.2M, a 103.51% increase from 2022.
- Bionano Genomics Inc. total liabilities for 2022 were 58.1M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bionano Genomics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $29 |
| 2024 | $41 |
| 2023 | $118 |
| 2022 | $58 |
| 2021 | $40 |
| 2020 | $25 |
| 2019 | $27 |
| 2018 | $15 |
| 2017 | $17 |
Bionano Genomics Inc. Total Liabilities — FAQ
Bionano Genomics Inc. (BNGO) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BNGO's total liabilities history?
The chart and table above show Bionano Genomics Inc.'s total liabilities by year and by quarter, including the growth rate.